Although radioiodine has been used to diagnose and treat differentiated thyroid cancer for more than 70 years, the accumulation of radioiodine in cancer cells was not fully understood until 1996, when the sodium iodide symporter (NIS) was first cloned by Carrasco et al. [8]. Here, SLC5A5 is linked to thyroid cancer.